Phase II study of trimetrexate in previously untreated patients with hepatocellular carcinoma. Southwest Oncology Group study 8712.
Harvey
W H
WH
Associates in Hematology and Oncology, Fort Myers, FL.
Fleming
T R
TR
Goodman
P J
PJ
Harvey
J H
JH
Rivkin
S E
SE
MacDonald
J S
JS
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D015507:Drugs, Investigational / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008113:Liver Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D016597:Trimetrexate / Q000009:adverse effects / Q000627:therapeutic use*
D015507:Drugs, Investigational; D016597:Trimetrexate